Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin G Sanda

Showing results (21-30 of 180) with videos related to

Pageof 18
Sort By:
Plos One|December 17, 2011
The role of the transcription factor SIM2 in prostate cancerBin Lu, John M Asara, Martin G Sanda, et al.
Plos One|April 3, 2014
Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell responseHaydn T Kissick, Martin G Sanda, Laura K Dunn, et al.
Urology|March 31, 2010
Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivorsKonrad M Szymanski, John T Wei, Rodney L Dunn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2020
Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group ReviewMichael A Liss, Robin J Leach, Martin G Sanda, et al.
Urologic Oncology|December 11, 2012
Outcomes sessionDavid F Penson, Daniel A Barocas, Neil Fleshner, et al.
Clinical Genitourinary Cancer|March 2, 2019
Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic LymphadenectomyMelissa A Taylor, Mehrdad Alemozaffar, Viraj A Master, et al.
Urology|February 5, 2008
Lower limits of detection using magnetic resonance imaging for solid components in cystic renal neoplasmsGregory S Adey, Ivan Pedrosa, Neil M Rofsky, et al.
Cancer|June 17, 2021
Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancerTimothy P Quinn, Martin G Sanda, David H Howard, et al.
Urology|May 7, 2002
Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomyCaleb P Nelson, Mark A Rubin, Myla Strawderman, et al.
BMC Medical Informatics and Decision Making|July 25, 2015
Usability evaluation and adaptation of the e-health Personal Patient Profile-Prostate decision aid for Spanish-speaking Latino menDonna L Berry, Barbara Halpenny, Jaclyn L F Bosco, et al.
Pageof 18

Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
Plos One|December 17, 2011
The role of the transcription factor SIM2 in prostate cancerBin Lu, John M Asara, Martin G Sanda, et al.
Plos One|April 3, 2014
Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell responseHaydn T Kissick, Martin G Sanda, Laura K Dunn, et al.
Urology|March 31, 2010
Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivorsKonrad M Szymanski, John T Wei, Rodney L Dunn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2020
Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group ReviewMichael A Liss, Robin J Leach, Martin G Sanda, et al.
Urologic Oncology|December 11, 2012
Outcomes sessionDavid F Penson, Daniel A Barocas, Neil Fleshner, et al.
Clinical Genitourinary Cancer|March 2, 2019
Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic LymphadenectomyMelissa A Taylor, Mehrdad Alemozaffar, Viraj A Master, et al.
Urology|February 5, 2008
Lower limits of detection using magnetic resonance imaging for solid components in cystic renal neoplasmsGregory S Adey, Ivan Pedrosa, Neil M Rofsky, et al.
Cancer|June 17, 2021
Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancerTimothy P Quinn, Martin G Sanda, David H Howard, et al.
Urology|May 7, 2002
Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomyCaleb P Nelson, Mark A Rubin, Myla Strawderman, et al.
BMC Medical Informatics and Decision Making|July 25, 2015
Usability evaluation and adaptation of the e-health Personal Patient Profile-Prostate decision aid for Spanish-speaking Latino menDonna L Berry, Barbara Halpenny, Jaclyn L F Bosco, et al.
Pageof 18